Reproducibility of biomarker identifications from mass spectrometry proteomic data in cancer studies
From MaRDI portal
Publication:2324977
Factor analysis and principal components; correspondence analysis (62H25) Classification and discrimination; cluster analysis (statistical aspects) (62H30) Applications of statistics to biology and medical sciences; meta analysis (62P10) Medical applications (general) (92C50) Biochemistry, molecular biology (92C40)
Recommendations
- Statistical methods for proteomic biomarker discovery based on feature extraction or functional modeling approaches
- Accounting for isotopic clustering in Fourier transform mass spectrometry data analysis for clinical diagnostic studies
- Feature selection and machine learning with mass spectrometry data for distinguishing cancer and non-cancer samples
- Finding causative genes from high-dimensional data: an appraisal of statistical and machine learning approaches
- An insight into high-resolution mass-spectrometry data
Cites work
- scientific article; zbMATH DE number 720689 (Why is no real title available?)
- Deriving chemosensitivity from cell lines: forensic bioinformatics and reproducible research in high-throughput biology
- Framework for making better predictions by directly estimating variables' predictivity
- Measuring reproducibility of high-throughput experiments
- Model-based or algorithm-based? Statistical evidence for diabetes and treatments using gene expression
- Robust Statistics
- Statistical methods for proteomic biomarker discovery based on feature extraction or functional modeling approaches
- The False Positive Risk: A Proposal Concerning What to Do About p-Values
- The control of the false discovery rate in multiple testing under dependency.
Cited in
(9)- Detection of cancer-specific markers amid massive mass spectral data
- The effects of nonignorable missing data on label-free mass spectrometry proteomics experiments
- Statistical methods for proteomic biomarker discovery based on feature extraction or functional modeling approaches
- Variance component analysis to assess protein quantification in biomarker discovery. Application to MALDI‐TOF mass spectrometry
- Finding causative genes from high-dimensional data: an appraisal of statistical and machine learning approaches
- Profiling the effects of short time-course cold ischemia on tumor protein phosphorylation using a Bayesian approach
- Developing a discrimination rule between breast cancer patients and controls using proteomics mass spectrometric data: a three-step approach
- Case-control breast cancer study of MALDI-TOF proteomic mass spectrometry data on serum samples
- Sampling uncertainty versus method uncertainty: a general framework with applications to omics biomarker selection
This page was built for publication: Reproducibility of biomarker identifications from mass spectrometry proteomic data in cancer studies
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q2324977)
